184 related articles for article (PubMed ID: 29603747)
1. Immune-mediated antitumor effect of a transplanted lymph node.
Maeda T; Hayashi T; Furukawa H; Iwasaki D; Ishikawa K; Funayama E; Murao N; Osawa M; Oyama A; Yamamoto Y
Int J Cancer; 2018 Sep; 143(5):1224-1235. PubMed ID: 29603747
[TBL] [Abstract][Full Text] [Related]
2. Sentinel node restoration by vascularized lymph node transfer in mice.
Kusajima EG; Yamamoto Y; Ishikawa K; Miura T; Funayama E; Osawa M; Takagi R; Maeda T
Microsurgery; 2024 Jan; 44(1):e30981. PubMed ID: 36321604
[TBL] [Abstract][Full Text] [Related]
3. Cancer cells regulate lymphocyte recruitment and leukocyte-endothelium interactions in the tumor-draining lymph node.
Carrière V; Colisson R; Jiguet-Jiglaire C; Bellard E; Bouche G; Al Saati T; Amalric F; Girard JP; M'Rini C
Cancer Res; 2005 Dec; 65(24):11639-48. PubMed ID: 16357175
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic Reconnection and Restoration of Lymphatic Flow by Nonvascularized Lymph Node Transplantation: Real-Time Fluorescence Imaging Using Indocyanine Green and Fluorescein Isothiocyanate-Dextran.
Maeda T; Yamamoto Y; Iwasaki D; Hayashi T; Funayama E; Oyama A; Murao N; Furukawa H
Lymphat Res Biol; 2018 Apr; 16(2):165-173. PubMed ID: 28956689
[TBL] [Abstract][Full Text] [Related]
5. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma.
Wiley HE; Gonzalez EB; Maki W; Wu MT; Hwang ST
J Natl Cancer Inst; 2001 Nov; 93(21):1638-43. PubMed ID: 11698568
[TBL] [Abstract][Full Text] [Related]
6. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis.
Harrell MI; Iritani BM; Ruddell A
Am J Pathol; 2007 Feb; 170(2):774-86. PubMed ID: 17255343
[TBL] [Abstract][Full Text] [Related]
7. Changes in high endothelial venules in lymph nodes after vascularized and nonvascularized lymph node transfer in a murine autograft model.
Ishikawa K; Funayama E; Maeda T; Hayashi T; Murao N; Osawa M; Ito R; Furukawa H; Oyama A; Yamamoto Y
J Surg Oncol; 2019 May; 119(6):700-707. PubMed ID: 30636050
[TBL] [Abstract][Full Text] [Related]
8. Vascularized lymph node transplantation induces graft-versus-host disease in chimeric hosts.
Francois CG; Brouha PC; Laurentin-Perez LA; Perez-Abadia G; Grossi FV; Barker JH; Hewitt CW; Kon M; Ramsamooj R; Maldonado C
Transplantation; 2006 May; 81(10):1435-41. PubMed ID: 16732182
[TBL] [Abstract][Full Text] [Related]
9. Tumor-induced lymph node alterations detected by MRI lymphography using gadolinium nanoparticles.
Partridge SC; Kurland BF; Liu CL; Ho RJ; Ruddell A
Sci Rep; 2015 Oct; 5():15641. PubMed ID: 26497382
[TBL] [Abstract][Full Text] [Related]
10. The augmenting effect of OK432-stimulated B cells on the in vitro generation of anti-tumor cytotoxic T lymphocytes from tumor-draining lymph node cells: the possible role of interleukin-12.
Shinomiya Y; Harada M; Tamada K; Kurosawa S; Okamoto T; Terao H; Takenoyama M; Ito O; Hirashima C; Li T; Shirakusa T; Nomoto K
In Vivo; 1997; 11(1):1-8. PubMed ID: 9067765
[TBL] [Abstract][Full Text] [Related]
11. Isolation based on L-selectin expression of immune effector T cells derived from tumor-draining lymph nodes.
Kagamu H; Touhalisky JE; Plautz GE; Krauss JC; Shu S
Cancer Res; 1996 Oct; 56(19):4338-42. PubMed ID: 8813119
[TBL] [Abstract][Full Text] [Related]
12. Local injection of OK432 can augment the TH1-type T-cell response in tumor-draining lymph node cells and increase their immunotherapeutical potential.
Okamoto T; Harada M; Tamada K; Yoshida H; Ito O; Kong YY; Takenoyama M; Hirashima C; Matsuzaki G; Nomoto K
Int J Cancer; 1997 Mar; 70(5):598-605. PubMed ID: 9052762
[TBL] [Abstract][Full Text] [Related]
13. Genetic defect in T lymphocyte-specific homing into peripheral lymph nodes.
Nakano H; Tamura T; Yoshimoto T; Yagita H; Miyasaka M; Butcher EC; Nariuchi H; Kakiuchi T; Matsuzawa A
Eur J Immunol; 1997 Jan; 27(1):215-21. PubMed ID: 9022021
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactivity of anti-CD3/IL-2 activated effector cells derived from lymph nodes draining heterologous clones of a murine tumor.
Matsumura T; Krinock RA; Chang AE; Shu S
Cancer Res; 1993 Sep; 53(18):4315-21. PubMed ID: 8364926
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
Shu S; Krinock RA; Matsumura T; Sussman JJ; Fox BA; Chang AE; Terman DS
J Immunol; 1994 Feb; 152(3):1277-88. PubMed ID: 8301131
[TBL] [Abstract][Full Text] [Related]
16. Systemic administration of interleukin-12 can restore the anti-tumor potential of B16 melanoma-draining lymph node cells impaired at a late tumor-bearing state.
Harada M; Tamada K; Abe K; Li T; Onoe Y; Tada H; Takenoyama M; Yasumoto K; Kimura G; Nomoto K
Int J Cancer; 1998 Jan; 75(3):400-5. PubMed ID: 9455801
[TBL] [Abstract][Full Text] [Related]
17. Treatment of intracranial tumors by systemic transfer of superantigen-activated tumor-draining lymph node T cells.
Inoue M; Plautz GE; Shu S
Cancer Res; 1996 Oct; 56(20):4702-8. PubMed ID: 8840987
[TBL] [Abstract][Full Text] [Related]
18. Quantity of lymph nodes correlates with improvement in lymphatic drainage in treatment of hind limb lymphedema with lymph node flap transfer in rats.
Nguyen DH; Chou PY; Hsieh YH; Momeni A; Fang YH; Patel KM; Yang CY; Cheng MH
Microsurgery; 2016 Mar; 36(3):239-45. PubMed ID: 25715830
[TBL] [Abstract][Full Text] [Related]
19. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of pleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs).
Ishii H; Yazawa T; Sato H; Suzuki T; Ikeda M; Hayashi Y; Takanashi Y; Kitamura H
Lung Cancer; 2004 Sep; 45(3):325-37. PubMed ID: 15301873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
